TEK and hepatocellular carcinoma: ANGPT1 (Angiopoietin-1), a ligand for Tie2 vascular endothelial-specific receptor tyrosine kinase, involved in the induction of HCC neovascularization and disease progression [78–80], was reported to harbor point mutations and HBV integrations in its intronic regions.